Clinical trial

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

NCT00900302

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2005-04-01

PhaseN/A

Study timeline

Study start (unknown)2005-04-01Date precision: month

Registry last updated2016-02-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancerunresolved

Interventions

protein expression analysisGENETIC

immunohistochemistry staining methodOTHER

laboratory biomarker analysisOTHER

biopsyPROCEDURE

Sponsors & collaborators

OHSU Knight Cancer Institutelead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

PortlandOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00900302 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.